Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yann Le Duff
Institution:
Medicines and Healthcare products Regulatory Agency
Observed institutions:
Jewish General Hospital,
Institut National de la Transfusion Sanguine,
Lady Davis Institute for Medical Research,
Medicines and Healthcare products Regulatory Agency,
McGill University,
National Institute for Biological Standards and Control
show all 6
ORCID:
0000-0001-8212-0935
Observed ORCID:
0000-0001-8212-0935
OpenAlex ID:
A5074024300
The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA
2015
·
Weijun Zhu
, Rongyue Lei
, et al.
·
Retrovirology
·
232
PDF
SAMHD1 Inhibits LINE-1 Retrotransposition by Promoting Stress Granule Formation
2015
·
Siqi Hu
, Jian Li
, et al.
·
PLoS Genetics
·
141
PDF
The Pre-S1 and Antigenic Loop Infectivity Determinants of the Hepatitis B Virus Envelope Proteins Are Functionally Independent
2009
·
Yann Le Duff
, Matthieu Blanchet
, et al.
·
Journal of Virology
·
98
DDX17 promotes the production of infectious HIV-1 particles through modulating viral RNA packaging and translation frameshift
2013
·
René-Pierre Lorgeoux
, Qinghua Pan
, et al.
·
Virology
·
43
PDF
Primate lentiviruses are differentially inhibited by interferon-induced transmembrane proteins
2014
·
Jin Qian
, Yann Le Duff
, et al.
·
Virology
·
42
PDF
A cautionary perspective regarding the isolation and serial propagation of SARS-CoV-2 in Vero cells
2021
·
Simon G. P. Funnell
, Babak Afrough
, et al.
·
npj Vaccines
·
41
PDF
Cytotoxicity of human antibodies targeting the circumsporozoite protein is amplified by 3D substrate and correlates with protection
2023
·
Manuela C. Aguirre-Botero
, Lawrence T. Wang
, et al.
·
Cell Reports
·
30
PDF
Clinical validation of a quantitative HIV-1 DNA droplet digital PCR assay: Applications for detecting occult HIV-1 infection and monitoring cell-associated HIV-1 dynamics across different subtypes in HIV-1 prevention and cure trials
2021
·
Laura Powell
, Adit Dhummakupt
, et al.
·
Journal of Clinical Virology
·
19
PDF
Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis
2024
·
Mark Manak
, Luc Gagnon
, et al.
·
The Lancet Microbe
·
18
PDF
Assessment of the Biological Impact of SARS-CoV-2 Genetic Variation Using an Authentic Virus Neutralisation Assay with Convalescent Plasma, Vaccinee Sera, and Standard Reagents
2023
·
Naomi S. Coombes
, Kevin R. Bewley
, et al.
·
Viruses
·
10
PDF
Evaluation of the cross reactivity of neutralising antibody response in vaccinated human and convalescent hamster sera against SARS-CoV-2 variants up to and including JN.1 using an authentic virus neutralisation assay
2023
·
Naomi S. Coombes
, Kevin R. Bewley
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
9
PDF
Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies
2022
·
Adéla Nacer
, Gaily Kivi
, et al.
·
Frontiers in Cellular and Infection Microbiology
·
9
PDF
Intrinsic host susceptibility among multiple species to intranasal SARS-CoV-2 identifies diverse virological, biodistribution and pathological outcomes
2022
·
Neil Berry
, Deborah Ferguson
, et al.
·
Scientific Reports
·
4
PDF
Assessing the Variability of Cell-Associated HIV DNA Quantification through a Multicenter Collaborative Study
2022
·
Yann Le Duff
, Kathleen Gärtner
, et al.
·
Microbiology Spectrum
·
3
Building a Repository to Support Research on Emerging Pathogens: How to Use the Experience of the Centre for AIDS Reagents
2020
·
Yann Le Duff
, Sarah Gilbert
, et al.
PDF
Etude de déterminants d'entrée virale et de morphogenèse du virus de l'hépatite B
2010
·
Yann Le Duff
Show more works
View as search
Works count:
16
Citation count:
699
H-index:
10
I10-index:
10
Year
Topic
Type